We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study.
- Authors
Nauck, Michael; Frid, Anders; Hermansen, Kjeld; Shah, Nalini S; Tankova, Tsvetalina; Mitha, Ismail H; Zdravkovic, Milan; Düring, Maria; Matthews, David R; LEAD-2 Study Group
- Abstract
The efficacy and safety of adding liraglutide (a glucagon-like peptide-1 receptor agonist) to metformin were compared with addition of placebo or glimepiride to metformin in subjects previously treated with oral antidiabetes (OAD) therapy.
- Publication
Diabetes care, 2009, Vol 32, Issue 1, p84
- ISSN
1935-5548
- Publication type
Journal Article
- DOI
10.2337/dc08-1355